English:Aging – Senescence as a time-dependent regeneration problem

aiMOOC

Aging – Senescence as a time-dependent regeneration problem

QR-Code

Introduction

Aging – Senescence as a time-dependent regeneration problem is an expert colloquium on a deceptively simple question: when does cellular senescence help regeneration, and when does it obstruct it? The course uses Yun, Davaapil and Brockes 2015 as a historical starting point, then tests that framework against more recent evidence from salamander limb regeneration, zebrafish fin regeneration, mammalian skeletal muscle, skin, bone, immune surveillance and modern senescence-mapping studies.

The central thesis to examine is not that senescence is intrinsically beneficial or harmful. Instead, you will treat senescence as a time-dependent, cell-type-dependent and clearance-dependent state within a changing regenerative system. A transient population that supplies useful paracrine signals and is then removed can have a very different effect from a phenotypically similar population that persists, changes its secretome, spreads senescence, occupies a progenitor niche or escapes immune clearance.

This expert course is designed for advanced university students, researchers and professional learners in Cell biology, Regenerative medicine, Aging, Immunology and Systems biology. You should already be comfortable with cell-cycle regulation, lineage markers, experimental controls and interpretation of animal models.

The axolotl is one of the vertebrate models that makes the relationship between regeneration and cellular senescence especially informative.

Load video

YouTube

YouTube might collect personal data. Privacy Policy

Continue Dismiss

The NIH Cellular Senescence Network overview is useful background for the heterogeneity of senescent cells, the difficulty of identifying them with one marker and the rationale for spatial mapping.

Historical Starting Point: Yun 2015

Yun, Davaapil and Brockes reported in 2015 that cellular senescence is induced during salamander limb regeneration and that senescent cells are efficiently cleared as regeneration proceeds. In newt limbs, senescence-associated beta-galactosidase positive cells were enriched during intermediate regenerative stages and then declined. Senescent cells were detected in several anatomical and cellular compartments, while macrophage depletion interfered with their clearance. The authors proposed that efficient immune surveillance prevents cumulative senescent-cell burden during repeated regeneration and may contribute to lifelong regenerative competence.

The important conceptual move was to separate senescence induction from senescence persistence. Injury could induce senescence without necessarily producing the chronic senescent-cell accumulation associated with mammalian aging. In that model, regeneration contains a cycle:

1. Tissue injury: Damage induces stress responses and regenerative signaling.
2. Cellular senescence: A subset of cells enters a stable growth-arrested, secretory state.
3. SASP: Senescent cells influence progenitors, matrix and immune recruitment.
4. Immune surveillance: Macrophages and other immune cells detect and remove senescent cells.
5. Regeneration: Tissue proceeds from proliferative and patterning phases into maturation without retaining a large senescent-cell burden.

That sequence is historically important, but current evidence shows that it is not universal.

Senescence Is a Dynamic State, Not a Single Marker

Cellular senescence is usually defined by a stable proliferative arrest accompanied by molecular and structural changes that may include p16, p21, persistent DNA-damage signaling, altered chromatin and nuclear lamina, lysosomal expansion, apoptosis resistance and a SASP. The exact combination varies by inducer, tissue, cell lineage, age and time after injury.

The 2024 MICSE guidelines emphasize that no single biomarker is sufficient in vivo. They recommend evidence from multiple independent senescence properties, including a cell-cycle inhibitor such as p16 or p21 plus auxiliary features such as DNA damage, Lamin B1 loss, altered lysosomal activity, SASP features or related phenotypes. They also recommend cell-type identification and, where causality is claimed, more than one strategy to reduce senescent-cell abundance or activity.

Cell-cycle exit is necessary to think about senescence, but absence of proliferation is not itself sufficient evidence. Quiescent cells, terminally differentiated cells, damaged cells and temporarily arrested cells can all be non-proliferative without fulfilling a full senescence program.

Marker Specificity Audit

Readout	What it can support	Major limitation in regeneration
p16 INK4a	Stable cell-cycle inhibition in many senescent states	Not universal; can be expressed outside senescence; p16-based reporters miss p16-low or p16-negative states and may enrich particular cell types
p21 CIP1	Stress-linked cell-cycle arrest and a senescence-associated state	Can be induced transiently after damage; p21-high populations can differ functionally from p16-high populations
SA-beta-gal	Increased lysosomal beta-galactosidase activity often enriched in senescent cells	Macrophages and other lysosome-rich cells can be positive; high lysosomal activity is not senescence-specific
Ki67 absence	Lack of active cycling	Cannot distinguish senescence from quiescence, differentiation or temporary arrest
gamma-H2AX and DNA-damage foci	Ongoing DNA-damage response	DNA damage also occurs in non-senescent injured cells; telomere-associated damage is more informative but technically demanding
Lamin B1 loss	Nuclear-envelope remodeling associated with many senescent states	Not universal and can vary by tissue and trigger
SASP factors	Functional output that can alter immunity, matrix and progenitor behavior	IL-6, CCL2, TGF-beta and related factors are also produced by inflammatory and stromal cells; SASP identity must be tied to the producing cell
Lipofuscin or metabolic changes	Persistent stress-associated cellular remodeling	Strongly dependent on cell type, age and tissue metabolism

A rigorous experiment therefore asks three distinct questions: Is the cell senescent? Which cell type is it? What does that population do at this regenerative phase?

Transient Versus Persistent Senescence

The phrase transient senescence should not be reduced to a fixed number of hours or days. In regeneration, a more useful definition is functional: a senescent-cell population appears after injury, performs context-dependent signaling, and is then removed or otherwise resolved before it becomes a chronic source of inflammatory, fibrotic or anti-proliferative signaling.

A simple phase-resolved model can be written conceptually as:

Change in senescent-cell burden for cell type c = induction - immune clearance - other loss or state transition.

For a cell type c, the sign of the net effect on regeneration depends on at least four time-varying components:

1. Burden: how many senescent cells are present.
2. Identity: whether they are fibroblasts, endothelial cells, myeloid cells, muscle stem cells, blastema cells or another lineage.
3. Secretory state: whether their SASP is dominated by mitogenic, chemotactic, matrix-remodeling, inflammatory or fibrotic signals.
4. Clearance competence: whether macrophages, natural killer cells and adaptive immune cells remove them at the appropriate phase.

Persistent senescence can therefore arise from excessive induction, slow clearance, immune dysfunction, resistance to immune killing or repeated injury that continually replenishes the state.

Regenerative Phases as a Senescence Control Problem

The phases of wound healing overlap rather than occurring as rigid blocks. Senescence should be interpreted within the same overlapping logic.

Early Injury and Inflammatory Phase

Immediately after injury, inflammatory signaling, danger-associated molecular patterns, hypoxia, oxidative stress and matrix disruption can induce arrest programs in several cell types. At this stage, a senescence-like secretome can be difficult to distinguish from the ordinary inflammatory secretome. Chemokines such as CCL2 and inflammatory cytokines are not specific proof of senescence.

Potentially useful early functions include immune recruitment, temporary suppression of damaged-cell proliferation, matrix remodeling and production of growth factors. Potentially harmful functions include excessive NF-kappa-B signaling, propagation of secondary senescence, blockade of progenitor expansion or premature fibrosis.

The important experimental question is not simply whether SASP factors increase, but whether those factors originate from experimentally validated senescent cells and whether their removal changes a regenerative endpoint.

Proliferative and Progenitor-Expansion Phase

In highly regenerative vertebrates, senescent cells can form a temporary signaling niche. In axolotl limb regeneration, Yu and colleagues showed that senescent blastemal cells promote progenitor expansion through WNT-pathway modulation. Their regenerative senescence program was molecularly distinct from a conventional DNA-damage-induced senescence program.

In newt muscle, Walters and colleagues found that secreted factors from senescent cells can promote muscle dedifferentiation and cell-cycle re-entry through an FGF-ERK-dependent mechanism, linking transient senescence to the generation of regenerative progenitors.

These studies strengthen one part of the Yun framework: a senescent population can be pro-regenerative when its signals are appropriately timed and resolved.

Remodeling and Maturation Phase

As proliferative demand declines, the same class of inflammatory or matrix-remodeling signals can become maladaptive if they persist. A SASP that initially recruits immune cells may later maintain inflammation; matrix-remodeling enzymes that facilitate tissue restructuring can later destabilize mature tissue; TGF-beta-linked outputs that assist repair can become pro-fibrotic.

This phase is where clearance becomes part of regeneration rather than an event after regeneration. Failure to remove senescent cells can prevent the tissue from switching from construction to maturation.

Macrophages are not merely scavengers. Their phenotype and timing can influence inflammation, progenitor behavior, matrix remodeling and clearance of senescent cells. Therefore, macrophage depletion experiments can affect regeneration through several pathways at once.

Current Counterevidence: Transient Does Not Automatically Mean Beneficial

A major challenge to a simple transient-good, persistent-bad model comes from mammalian skeletal muscle. Moiseeva and colleagues mapped senescent cells in regenerating mouse muscle and found major populations among myeloid cells, fibroadipogenic progenitors and muscle stem-cell lineages. Senescent cells appeared after injury in young and old muscle, but were more abundant and persistent in old animals. Their secretory programs were enriched for inflammatory and fibrotic signals.

Crucially, reducing senescent-cell burden genetically or with dasatinib plus quercetin accelerated regeneration even in young animals. Starting treatment at three days after injury also produced benefit, and longer treatment in dystrophic mdx muscle improved fiber size, fibrosis and muscle force. This result directly challenges the proposition that a transient senescent-cell wave is necessarily pro-regenerative.

The correct inference is narrower: the effect of transient senescence depends on which cells enter the state, which signals they produce, which progenitors receive those signals and how rapidly the state resolves.

Cross-Species Evidence

Adult zebrafish provide another regeneration-competent vertebrate model. After caudal-fin amputation, senescence-associated cells appear at the injury site. Da Silva-Álvarez and colleagues used the senolytic navitoclax and found that early removal of these cells reduced fin regeneration measured at eight days after amputation. The result supports a causal pro-regenerative role for the early senescence response in that model.

The zebrafish, newt and axolotl data therefore contrast with the mouse muscle data. The contrast is scientifically productive because it rules out a universal rule based only on duration.

Skin: Marker-Defined Populations Can Have Opposite Effects

Cutaneous wound healing illustrates a second problem: different marker-defined senescent populations in the same organ may not be equivalent.

Older work reported that p16-high senescent cells promoted wound closure through PDGF-AA-associated signaling, and eliminating these cells delayed repair. However, the 2014 Developmental Cell paper that established this result received an Expression of Concern in 2026. Its conclusions should therefore be treated as provisional rather than as a settled foundation.

More recent work used a p21-based model and spatial transcriptomics to identify p21-high wound-associated cells that were largely distinct from p16-high cells. Clearing the p21-high population accelerated wound closure and was linked partly to reduced NF-kappa-B activity.

This is not a contradiction that can be solved by averaging the two studies. It is evidence that p16-high and p21-high compartments can represent different cell populations, different phases or different functional states.

p16-Negative and Marker-Incomplete States

A p16 reporter does not define the entire senescent-cell universe. In regenerating muscle, multi-marker and transcriptomic approaches have shown that classical markers such as p16, p21, IL-6 or IL-1 are not uniformly expressed by every senescence-enriched cell. Therefore, a p16-based ablation experiment can underestimate total senescence and preferentially remove one functional subset.

The practical consequence is that a negative p16 result has at least three interpretations:

1. The cell is not senescent.
2. The cell is senescent but uses a different arrest program or expresses p16 below detection.
3. The measured time point missed a p16-positive phase in a dynamic state.

To distinguish these possibilities, combine lineage identity, p21 or another arrest-associated readout, proliferation history, DNA-damage or structural markers, lysosomal or metabolic features and functional perturbation.

Cell-Type Shifts Can Masquerade as Senescence Changes

Bulk tissue measurements are especially vulnerable to composition effects. Imagine that p16 mRNA doubles in an injured muscle. This can occur because each fibroblast expresses more p16, because p16-high fibroblasts become more abundant, because macrophages infiltrate the tissue and contribute p16 signal, or because the tissue loses another cell population and thereby changes the denominator.

Single-cell and spatial methods are therefore important. Recent skeletal-muscle atlases show age-related changes in immune, stromal, vascular and stem-cell states across regeneration. A change in a tissue-level senescence score can reflect both true state transitions and altered abundance of the cell types that carry those states.

A strong analysis should report both:

Within-cell-type state change: how senescence-associated features change inside a defined lineage.

Between-cell-type composition change: how the abundance of lineages changes over the same time course.

SASP Is a Phase-Dependent Network

The SASP is not a fixed cytokine list. It can contain cytokines, chemokines, growth factors, proteases, extracellular-matrix regulators, lipids, extracellular vesicles and other secreted products. Its composition changes with trigger, cell identity, tissue and time.

A phase-resolved interpretation is more informative than labeling a factor as simply good or bad:

Regenerative phase	Potentially useful SASP functions	Potentially harmful SASP functions
Early inflammation	Recruit phagocytes; coordinate danger response; transiently restrain damaged-cell proliferation	Excess cytokine amplification; collateral tissue damage; secondary senescence
Progenitor expansion	WNT, FGF, PDGF or other mitogenic support; plasticity and dedifferentiation	Suppression of stem-cell proliferation; exhaustion of progenitors; inflammatory niche formation
Matrix construction	Matrix remodeling; angiogenic support; recruitment of stromal cells	Fibrosis; aberrant stiffness; prolonged TGF-beta signaling
Maturation	Limited remodeling signals	Persistent inflammation, fibrosis, impaired functional restoration and failure to return to homeostasis

Load video

YouTube

YouTube might collect personal data. Privacy Policy

Continue Dismiss

This seminar by Marco Demaria provides historical context for the development of senescence and senolytic concepts. Because the field has changed substantially, compare its claims with newer marker guidelines and current model-specific evidence rather than treating it as a final summary.

Immune Clearance as a Regenerative Variable

Immune surveillance of senescent cells involves macrophages, natural killer cells, T cells and other immune components. A SASP can make senescent cells visible by recruiting immune cells, but senescent cells can also develop immune-evasion features. Aging can weaken clearance by changing both the immune system and the senescent-cell target.

The Yun model therefore becomes more precise if you distinguish three rates:

Senescence induction rate after injury.

Senescent-cell clearance rate during immune resolution.

Regenerative progression rate through proliferation, patterning and maturation.

Aging can uncouple these rates. Even if induction is unchanged, slower immune clearance can lengthen exposure to a damaging SASP. Conversely, rapid pharmacological senolysis can remove cells before their useful signals have completed their function.

Early Versus Late Selective Removal

The most informative experiment would randomize the same injury model to removal of a validated senescent-cell population at multiple phases and follow long-term structural and functional outcomes. The field still contains fewer such same-model timing studies than would be desirable.

Current evidence nevertheless supports several timing contrasts:

Model	Removal timing	Reported outcome	Interpretation
Zebrafish caudal fin	Early navitoclax after amputation	Reduced regenerate length at eight days	Early senescence can be required for efficient regeneration
Axolotl limb	Loss-of-function manipulation of blastemal senescence	Reduced progenitor expansion and blastema outgrowth	Senescent blastemal cells can form a pro-proliferative niche
Mouse skeletal muscle	Continuous or starting around three days after injury	Faster regeneration and improved short-term force	Even transient injury-induced senescence can be anti-regenerative in this tissue
Dystrophic mouse muscle	Repeated treatment over two months	Reduced fibrosis and improved muscle force	Persistent senescent-cell burden can contribute to chronic regenerative failure
Mouse fracture callus	Intermittent senolytic treatment during healing	Faster healing, increased callus bone measures and improved biomechanical outcomes in reported studies	Transient senescence is not automatically beneficial in bone
Mouse skin	Marker-selective p21-high clearance during healing	Faster wound closure	Different marker-defined senescent populations can have different net effects

A key research gap is a rigorous early-versus-late selective removal experiment within the same tissue using the same senescent-cell definition and long-term endpoints. Short-term wound area, blastema size or myofiber diameter should not automatically be equated with durable functional regeneration.

Long-Term Endpoints

A regeneration study should follow the function appropriate to the tissue, not only the speed of early closure.

Useful long-term endpoints include:

1. Skeletal muscle: force generation, fatigue resistance, fiber architecture, satellite-cell reserve and fibrosis.
2. Bone healing: mechanical strength, mineralization, callus remodeling and restoration of normal geometry.
3. Skin: tensile strength, scar architecture, innervation, appendage restoration and recurrence of chronic inflammation.
4. Limb regeneration: pattern fidelity, joint structure, muscle integration, innervation, vascularization and repeated-regeneration competence.
5. Immune function: restoration of surveillance capacity without long-term depletion of beneficial immune populations.

The strongest senolysis experiment therefore asks not only whether tissue regenerates faster, but whether it regenerates better and durably.

When Would Senolysis Worsen Regeneration?

Senolysis is most likely to worsen regeneration under conditions in which the cells being removed are performing a necessary phase-specific function or the intervention damages other regenerative components.

Evidence-supported or strongly evidence-consistent conditions include:

1. Early removal of a pro-regenerative transient population: This is supported by zebrafish fin regeneration and by salamander studies in which senescent cells support progenitor expansion or dedifferentiation.
2. A regenerative system with already efficient immune clearance: If endogenous clearance is rapid, pharmacological removal may truncate useful signaling rather than solve persistence.
3. Targeting the wrong senescent subset: Removing p16-high cells may produce a different effect from removing p21-high cells because these markers can define different populations.
4. Removal during a phase that requires SASP-derived mitogenic or plasticity signals: WNT, FGF-ERK or other paracrine pathways can be required for progenitor behavior in highly regenerative species.
5. Loss of fibrosis-limiting or remodeling cells: Some senescent myofibroblast-like states may help terminate excessive proliferation or alter matrix deposition; indiscriminate clearance could disturb that transition.
6. Insufficient phagocytic capacity after senolysis: Killing many cells creates debris that still has to be cleared. In an aged or immunocompromised tissue, secondary inflammatory consequences are a plausible risk.
7. Off-target toxicity in progenitors or immune cells: Senolytic sensitivity is based on survival dependencies that may not be unique to senescent cells.
8. A p16-negative dominant senescence program: A p16-selective strategy could remove a minority subset, alter the cellular ecosystem and leave the dominant damaging state untouched.
9. Repeated dosing across the whole regenerative window: A schedule that extends from inflammation through maturation may remove cell populations with different functions at different times.
10. Using short-term surrogate endpoints to guide dosing: A treatment that speeds closure can still worsen scar quality, mechanical function, innervation or future regenerative capacity.

These conditions are not a clinical prescription. They are hypotheses and experimentally supported cautions that should shape study design.

The 2026 p16-3MR Model Controversy

A major methodological development in 2026 concerns the widely used p16-3MR mouse model. Hori and colleagues reported weak reporter signals and failure of ganciclovir to eliminate senescent cells under their experimental conditions, arguing that all three transgenes in the model showed functional deficiencies.

A published response disputed a blanket conclusion that the model is non-functional, noting independent studies and orthogonal validation of p16-associated phenotypes. The dispute is unresolved at the level of universal model validity. For an expert reader, the practical lesson is clear: do not let the transgene serve as its own validation. Include wild-type controls, measure target-cell depletion with independent markers, document pharmacokinetics where relevant and replicate key causal claims with a second method.

This issue is especially important when interpreting older wound-healing or regeneration studies that rely heavily on one p16 reporter-ablation system.

A Phase-Resolved Experimental Design

To test whether senescence is causal in a regenerative system, design the study around time, cell identity and function.

Phase 1: Build the map. Sample uninjured tissue and several regenerative phases. Use spatial or single-cell methods to identify which lineages acquire senescence-associated features.

Phase 2: Validate the state. Within each candidate lineage, combine a cell-cycle inhibitor, a second arrest or proliferation readout and at least two auxiliary senescence features. Distinguish senescence from quiescence, terminal differentiation and ordinary inflammation.

Phase 3: Map the secretome. Identify which SASP components are produced by which validated senescent population at which time. Do not infer cellular origin from bulk cytokine measurements.

Phase 4: Measure immune clearance. Quantify macrophage, natural killer cell and T-cell interactions, disappearance kinetics and evidence of phagocytosis or immune escape.

Phase 5: Perturb by timing. Compare early selective removal, late selective removal, persistent removal and no removal. Add a senomorphic arm if possible to distinguish effects of killing the cell from effects of modifying its secretome.

Phase 6: Use long-term endpoints. Follow tissue mechanics, pattern, fibrosis, innervation, vascularization, functional reserve and response to a second injury.

Phase 7: Replicate causality. Use at least two mechanistically independent perturbations and verify that each actually changes the intended senescent-cell population.

Load video

YouTube

YouTube might collect personal data. Privacy Policy

Continue Dismiss

This 2024 seminar on cellular senescence and senolytics can be used to compare therapeutic concepts with the stricter phase-resolved experimental logic developed in this course.

Evidence Matrix for the Colloquium

Study or evidence class	System	Main result	What it supports	Main caution
Yun et al. 2015	Newt limb	Senescence rises during regeneration and is later cleared; macrophages contribute to clearance	Clearance kinetics are part of regenerative biology	Marker and perturbation tools were less developed than current standards
Da Silva-Álvarez et al. 2020	Zebrafish fin	Early navitoclax impairs regeneration	Transient senescence can be pro-regenerative	Pharmacological selectivity and tissue-specific effects require controls
Walters et al. 2023	Newt muscle	Senescent cells promote dedifferentiation through FGF-ERK signaling	SASP can drive regenerative plasticity	Gain-of-function and conditioned-medium paradigms must be related carefully to endogenous cell numbers
Yu et al. 2023	Axolotl limb	Senescent blastemal cells support progenitor expansion through WNT modulation	Senescence can form a pro-regenerative niche	Results cannot be generalized automatically to mammalian wounds
Moiseeva et al. 2023	Mouse muscle	Senescent cells create inflammatory and fibrotic niche; removal improves regeneration	Transient senescence can also be anti-regenerative	p16-3MR interpretations now require attention to the 2026 model controversy
Gasek et al. 2025	Mouse skin	p21-high clearance accelerates closure; p21-high and p16-high compartments differ	Marker-defined senescent populations are functionally heterogeneous	Wound closure is not the only long-term endpoint
MICSE 2024	Cross-system methodology	Recommends multi-marker, cell-type-aware validation	No universal marker identifies senescence	Guidelines improve evidence quality but do not replace functional experiments
Hori et al. 2026 and response	p16-3MR model	Reporter and ablation performance contested	Tool validation is itself an experimental variable	The controversy does not automatically invalidate all prior phenotypes

Selected Sources

For further reading, compare the following open or openly indexed resources:

1. Yun et al. 2015 in eLife
2. Walters et al. 2023 on newt limb regeneration
3. Yu et al. 2023 on axolotl blastemal senescence
4. Moiseeva et al. on senescence in skeletal muscle regeneration
5. MICSE guidelines for in vivo senescence experiments
6. Gasek et al. on p21-high cells in wound healing
7. Hori et al. 2026 on p16-3MR limitations

Interactive Tasks

Quiz: Test Your Knowledge

What was a central finding of Yun and colleagues in salamander limb regeneration? (Senescent cells were induced and later efficiently cleared) (!Senescent cells never appeared after injury) (!Macrophages permanently blocked regeneration) (!Senescence increased after every amputation without resolution)

Why is p16 alone insufficient to identify all senescent cells in vivo? (Senescent states are heterogeneous and p16 is not universally expressed) (!p16 is found only in bacteria) (!p16 measures extracellular matrix stiffness) (!p16 is a macrophage-specific receptor)

What did zebrafish fin experiments with navitoclax show? (Early senescent-cell removal impaired regeneration) (!Early senescent-cell removal doubled fin length) (!Navitoclax converted fins into limbs) (!Senescence was absent after amputation)

What did the mouse skeletal muscle senescence atlas challenge? (The idea that transient senescence is always beneficial after acute injury) (!The existence of muscle stem cells) (!The role of DNA in cell division) (!The presence of macrophages in injured tissue)

What is a key limitation of SA-beta-gal as a single senescence marker? (Lysosome-rich non-senescent cells can also show high activity) (!It can only be measured in plants) (!It directly measures tissue force) (!It identifies only dividing cells)

Why must SASP factors be linked to their cellular source? (Many SASP-associated factors are also produced by non-senescent inflammatory cells) (!SASP factors exist only inside the nucleus) (!Every cell secretes the same SASP) (!SASP factors cannot be measured experimentally)

What did axolotl blastemal studies identify as one pro-regenerative mechanism? (WNT pathway modulation that supports progenitor expansion) (!Permanent elimination of all progenitor cells) (!Complete suppression of immune recruitment) (!Replacement of DNA by RNA)

What is the strongest design for testing timing of senolysis? (Compare phase-specific removal with matched long-term functional endpoints) (!Measure one marker at one time point) (!Use only a bulk cytokine assay) (!Assume all tissues respond identically)

Which statement best reflects modern senescence marker guidance? (Multiple complementary markers should be combined with cell-type information) (!One universal marker is sufficient in every tissue) (!Only p16 should be measured) (!Only cell size is needed)

Under which condition is senolysis most plausibly harmful to regeneration? (When it removes a transient population supplying required early regenerative signals) (!When no target cells are present) (!When the tissue has already completed all remodeling) (!When the assay contains no living cells)

Memory Game

Transient senescence	Injury-induced senescent state that resolves before chronic accumulation
Persistent senescence	Senescent state that remains and can sustain maladaptive signaling
SASP	Secretory program through which senescent cells alter neighboring cells and tissue
Immunosurveillance	Immune recognition and removal of senescent cells
Senolysis	Selective killing of senescent cells
Senomorphic	Intervention that modifies harmful senescent-cell outputs without necessarily killing the cell
Blastema	Progenitor-rich structure that drives appendage regeneration in salamanders

Drag and Drop

Match the correct terms.	Topic
Marker multiplexing	Combining independent senescence properties in the same experimental system
Cell-type audit	Determining which lineage actually carries the measured senescence state
Early senolysis	Removing target cells during inflammatory or progenitor-expansion phases
Late senolysis	Removing target cells during resolution or remodeling phases
Long-term endpoint	Measuring durable structure and function after the regenerative process

...

Crossword Puzzle

Senescence	What stress-associated cell state combines stable growth arrest with broader phenotypic remodeling?
Macrophage	Which phagocytic immune cell was implicated in clearance during salamander regeneration?
Blastema	What progenitor-rich structure forms during salamander limb regeneration?
Clearance	What process removes senescent cells from a regenerating tissue?
Navitoclax	Which senolytic was used in the zebrafish fin regeneration study?
Fibrosis	What excessive matrix-producing outcome can persistent inflammatory signaling promote?

Cloze Text

Complete the text.

Yun and colleagues showed that senescent cells can be induced during salamander limb . Their later disappearance depended in part on immune . A secretory program associated with senescent cells is called the . Modern guidelines warn that no single molecular identifies every senescent cell. In zebrafish fins, early senolysis can regeneration. In mouse skeletal muscle, senescent cells can create an inflammatory and fibrotic . The same marker does not necessarily identify the same functional population in every . Therefore, senolytic timing should be evaluated with long-term functional .

Open-Ended Tasks

Easy

1. Senescence timeline: Draw a phase diagram showing injury, senescence induction, SASP activity, immune clearance and tissue maturation, and annotate where each variable could become maladaptive.
2. Marker audit: Create a one-page comparison of p16, p21, SA-beta-gal, Ki67, Lamin B1 and DNA-damage markers, including one false-positive or false-negative risk for each.
3. Model comparison: Produce a concept map comparing salamander limb, zebrafish fin and mouse muscle regeneration.
4. SASP storyboard: Create a six-panel illustration showing how the same secreted factor could be useful early but harmful when persistent.

Standard

1. Yun 2015 replication plan: Design a modern replication of the Yun study using cell-type markers, spatial profiling and multiple senescence readouts.
2. Early versus late senolysis: Propose an experiment with early, late, continuous and control treatment arms and define at least three long-term endpoints.
3. Single-cell interpretation: Build a mock single-cell dataset in which bulk p16 rises because cell composition changes, then explain how you would distinguish composition from within-lineage induction.
4. Research interview: Interview a researcher in regeneration, immunology or aging about what they consider sufficient evidence that an in vivo cell is senescent.

Advanced

1. Causal senescence model: Develop a mathematical or computational model in which senescent-cell induction, clearance and SASP potency vary over time and test conditions that switch the predicted effect from beneficial to harmful.
2. p16-3MR controversy: Conduct a structured evidence review of the 2026 p16-3MR criticism and response, separating model-performance evidence from biological conclusions that were independently validated.
3. Cross-tissue senolysis protocol: Design a preregistered study comparing skin, muscle and bone with identical timing logic but tissue-specific functional endpoints.
4. Translational risk analysis: Produce a research proposal specifying when senolysis should be withheld after acute injury and what biomarkers would be required before treatment.

Learning Assessment

1. Phase-resolved interpretation: Given a time course of p16, p21, macrophage abundance and force recovery, infer at least two competing causal models and state what experiment would discriminate between them.
2. Marker triangulation: Evaluate a paper that calls cells senescent based only on SA-beta-gal and Ki67 loss, and design a stronger validation strategy.
3. Selective removal reasoning: Explain why clearing p21-high cells and clearing p16-high cells can produce different outcomes even in the same injured tissue.
4. Cross-species transfer: Decide which conclusions from axolotl limb regeneration can be tested directly in mouse muscle and which require reformulation because the regenerative architecture differs.
5. Long-term endpoint design: Replace a short-term wound-closure endpoint with a panel that measures durability, fibrosis, mechanics and response to a second injury.
6. Senolysis harm criterion: Define a falsifiable condition under which senolysis would worsen regeneration and specify the observations required to support it.

Evidence of Learning

Strong evidence of learning includes the ability to distinguish cellular senescence from generic cell-cycle arrest, explain why marker specificity is conditional, model senescent-cell burden as a balance between induction and clearance, interpret SASP as a dynamic network rather than a fixed list, and compare regenerative systems without assuming that results transfer unchanged across species.

You should be able to produce a phase-resolved experimental design, identify cell-type composition as a confounder, explain p16-low or p16-negative senescent states, evaluate early and late senolysis separately, and defend a choice of long-term structural and functional endpoints.

Advanced mastery is demonstrated when you can explain how apparently contradictory results from salamander, zebrafish, mouse muscle, skin and bone can coexist within one conditional framework and when you can specify the exact evidence that would cause you to revise that framework.

OERs on the Topic

Useful related open resources include Cellular senescence, Tissue regeneration, Wound healing, Macrophage, Stem cell niche, Inflammation, Fibrosis, Zebrafish and Axolotl.

Linked Learning Areas

Aging – Senescence as a time-dependent regeneration problem Cellular senescence Senescence-associated secretory phenotype Regeneration Immune surveillance Macrophage Stem cell niche Wound healing Senolytic Systems biology